ITCI
Natixis Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,085
| Closed | -$2.1M | – | 1693 |
|
|
2024
Q4 | $2.1M | Buy |
25,085
+502
| +2% | +$41.9K | ﹤0.01% | 1082 |
|
|
2024
Q3 | $1.8M | Sell |
24,583
-7,077
| -22% | -$518K | ﹤0.01% | 1119 |
|
|
2024
Q2 | $2.17M | Sell |
31,660
-3,592
| -10% | -$246K | ﹤0.01% | 1022 |
|
|
2024
Q1 | $2.44M | Buy |
35,252
+1,364
| +4% | +$94.4K | 0.01% | 974 |
|
|
2023
Q4 | $2.43M | Buy |
33,888
+2,554
| +8% | +$183K | 0.01% | 946 |
|
|
2023
Q3 | $1.63M | Sell |
31,334
-2,510
| -7% | -$131K | 0.01% | 1048 |
|
|
2023
Q2 | $2.14M | Buy |
33,844
+6,385
| +23% | +$404K | 0.01% | 941 |
|
|
2023
Q1 | $1.49M | Buy |
27,459
+11
| +0% | +$596 | 0.01% | 1029 |
|
|
2022
Q4 | $1.45M | Buy |
27,448
+6,442
| +31% | +$341K | 0.01% | 1033 |
|
|
2022
Q3 | $977K | Buy |
21,006
+2,099
| +11% | +$97.6K | ﹤0.01% | 1117 |
|
|
2022
Q2 | $1.08M | Buy |
18,907
+742
| +4% | +$42.3K | ﹤0.01% | 1103 |
|
|
2022
Q1 | $1.11M | Buy |
18,165
+7,558
| +71% | +$463K | ﹤0.01% | 1099 |
|
|
2021
Q4 | $555K | Buy |
+10,607
| New | +$555K | ﹤0.01% | 1231 |
|
|
2021
Q1 | – | Sell |
-10,758
| Closed | -$342K | – | 1302 |
|
|
2020
Q4 | $342K | Buy |
+10,758
| New | +$342K | ﹤0.01% | 1166 |
|